AGC (5201) Q2 2025 earnings summary

Executive summary

• Net sales for the first half of FY2025 were ¥995.5 billion, down ¥19.7 billion year-over-year, mainly due to lower shipments in Architectural Glass, lower PVC resin prices, and yen appreciation, despite improved product mix in Automotive Glass and higher Performance Chemicals prices.

• Operating profit declined by ¥2.7 billion to ¥54.0 billion, impacted by lower sales and rising raw material and fuel costs.

• Net income attributable to owners increased by ¥128.4 billion to ¥13.9 billion, driven by the absence of prior-year one-off losses from the Russian business transfer and biopharmaceutical CDMO impairment.

• Downward revision of FY2025 outlook due to underperformance in Chemicals, Life Science, and Electronics segments.

Financial highlights

• Total assets stood at ¥2,804.9 billion, down ¥84.8 billion from year-end, with a D/E ratio of 0.41 as of June 30, 2025.

• Operating cash flow was ¥117.1 billion; investing cash flow was minus ¥87.7 billion, resulting in free cash flow of ¥29.4 billion.

• CapEx was ¥96.9 billion, depreciation ¥88.2 billion, and R&D ¥28.5 billion.

• Operating profit margin for 1H FY2025 was 5.4%, with ROE at 4.0%.

• Basic earnings per share were ¥65.59, compared to a loss of ¥540.26 per share in the prior year.

Outlook and guidance

• Full-year FY2025 forecast revised: net sales expected at ¥2,050 billion (down ¥100 billion), operating profit at ¥120 billion (down ¥30 billion), and net income at ¥57 billion (down ¥23 billion).

• Dividend forecast remains unchanged at ¥210 per share, maintaining a stable dividend policy targeting approximately 3% ROE.

• FX assumptions updated to ¥147/USD and ¥163/EUR.

• Second half expected to see stronger performance, with operating profit projected at ¥66 billion versus ¥54 billion in the first half.

• ROE target of 5% or higher in 2026, with structural reforms and cost reductions planned.